GENOVA, Inc.

Tokyo Stock Exchange 9341.T

GENOVA, Inc. EPS (Diluted) for the year ending March 31, 2024: USD 0.64

GENOVA, Inc. EPS (Diluted) is USD 0.64 for the year ending March 31, 2024, a 15.94% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.
  • GENOVA, Inc. EPS (Diluted) for the year ending March 31, 2023 was USD 0.55, a 55.84% change year over year.
  • GENOVA, Inc. EPS (Diluted) for the year ending March 31, 2022 was USD 0.35, a 5.00% change year over year.
  • GENOVA, Inc. EPS (Diluted) for the year ending March 31, 2021 was USD 0.34.
Key data
Date EPS (Diluted) Shares (Diluted, Weighted) Shares (Basic, Weighted) Revenue
Market news
SV Wall Street
Tokyo Stock Exchange: 9341.T

GENOVA, Inc.

CEO Mr. Tomoki Hirase
IPO Date Dec. 23, 2022
Location Japan
Headquarters Shibuya Hikarie
Employees 352
Sector Health Care
Industries
Hospitals & Clinics Medical Instruments Pharmaceuticals Telehealth
Description

GENOVA, Inc. engages in the medical platform and smart clinic businesses in Japan. It offers Medical Doc, a platform that distributes articles for medical institutions, patient experience articles, treatment videos, and medical-related articles. It also provides Smart Clinic, an online medical treatment and consultation service, which offers medical treatment at home or work for users without going to a hospital. In addition, the company offers NOMOCa-Stand, a smart and simple automatic payment and reception machine; NOMOCa-Regi, a self-pay machine dedicated to the clinic; and CLINIC BOT, an AI Chatbot System. The company was founded in 2005 and is headquartered in Tokyo, Japan.

StockViz Staff

February 1, 2025

Any question? Send us an email